January 16, 2018Open Access

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Key points are not available for this paper at this time.

Clinicaltrials.gov identifier: NCT02155647.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Howard L. Kaufman

Jeffery S. Russell

Omid Hamid

Journal for ImmunoTherapy of Cancer

SHILAP Revista de lepidopterología

Cornell University

Inserm

Dana-Farber Cancer Institute

Building similarity graph...

Analyzing shared references across papers